Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-019382
Filing Date
2025-07-03
Accepted
2025-07-03 19:49:20
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 form4-07032025_110716.html 4  
1 form4-07032025_110716.xml 4 3389
  Complete submission text file 0001415889-25-019382.txt   4873
Mailing Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 642-6670
PMV Pharmaceuticals, Inc. (Issuer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PMV PHARMACEUTICALS, INC. 400 ALEXANDER PARK DRIVE, SUITE 301 PRINCETON NJ 08540
Business Address
Carulli Michael (Reporting) CIK: 0002006668 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39539 | Film No.: 251106781